{"id":"https://openalex.org/W3023624685","doi":null,"title":"Acquired EGFr TKI resistance associated with mutation of the EGFr.","display_name":"Acquired EGFr TKI resistance associated with mutation of the EGFr.","publication_year":2004,"publication_date":"2004-04-01","ids":{"openalex":"https://openalex.org/W3023624685","mag":"3023624685"},"language":"en","primary_location":{"id":"mag:3023624685","doi":null,"is_oa":false,"landing_page_url":"https://cancerres.aacrjournals.org/content/64/7_Supplement/570.3","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Cancer Research","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049137444","display_name":"Joyce Ellen Ohm","orcid":"https://orcid.org/0000-0002-7390-8701","observed_orcids":["https://orcid.org/0000-0002-7390-8701"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joyce E. Ohm","raw_affiliation_strings":["Vanderbilt University, Nashville, TN"],"raw_orcid":"https://orcid.org/0000-0002-7390-8701","affiliations":[{"raw_affiliation_string":"Vanderbilt University, Nashville, TN","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113793371","display_name":"Joseph M. Amann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph M. Amann","raw_affiliation_strings":["Vanderbilt University, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University, Nashville, TN","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059652753","display_name":"David Paul Carbone","orcid":"https://orcid.org/0000-0003-3002-1921","observed_orcids":["https://orcid.org/0000-0003-3002-1921"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David P. Carbone","raw_affiliation_strings":["Vanderbilt University, Nashville, TN"],"raw_orcid":"https://orcid.org/0000-0003-3002-1921","affiliations":[{"raw_affiliation_string":"Vanderbilt University, Nashville, TN","institution_ids":["https://openalex.org/I200719446"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I200719446"],"apc_list":null,"apc_paid":null,"fwci":0.2801,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.71232205,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"64","issue":null,"first_page":"570","last_page":"570"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.6209999918937683},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.9359999895095825},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.9020000100135803},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8899999856948853},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9359999895095825},{"id":"https://openalex.org/keywords/exon-19-deletion","display_name":"exon 19 deletion","score":0.9210000038146973},{"id":"https://openalex.org/keywords/kinase-domain-mutations","display_name":"kinase domain mutations","score":0.7099999785423279},{"id":"https://openalex.org/keywords/drug-binding-pocket","display_name":"drug-binding pocket","score":0.796999990940094},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.6549999713897705},{"id":"https://openalex.org/keywords/anti-egfr-monoclonal-antibody","display_name":"anti-EGFR monoclonal antibody","score":0.7829999923706055}],"concepts":[{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.8561456203460693},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6872683167457581},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.589383602142334},{"id":"https://openalex.org/C36823959","wikidata":"https://www.wikidata.org/wiki/Q373027","display_name":"Exon","level":3,"score":0.5676997900009155},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.558634340763092},{"id":"https://openalex.org/C176944494","wikidata":"https://www.wikidata.org/wiki/Q1415380","display_name":"Point mutation","level":4,"score":0.4927721321582794},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.48545271158218384},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46226513385772705},{"id":"https://openalex.org/C32619005","wikidata":"https://www.wikidata.org/wiki/Q24768234","display_name":"Protein kinase domain","level":4,"score":0.43858981132507324},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.42682385444641113},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4169677495956421},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.41450071334838867},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3501259982585907},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33333367109298706},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2621854841709137},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1410488784313202},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.08592662215232849},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.07687544822692871}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3023624685","doi":null,"is_oa":false,"landing_page_url":"https://cancerres.aacrjournals.org/content/64/7_Supplement/570.3","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Cancer Research","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2686921864","https://openalex.org/W2006984558","https://openalex.org/W2247029248","https://openalex.org/W1511842905","https://openalex.org/W7096777428","https://openalex.org/W1526653010","https://openalex.org/W2898232661","https://openalex.org/W2029679234","https://openalex.org/W2752876052","https://openalex.org/W2521160276"],"abstract_inverted_index":{"2464":[0],"Lung":[2],"cancer":[3,9,28],"is":[4,68,91,243,258,315],"the":[5,12,31,41,66,70,86,95,98,126,145,156,159,177,212,249,252,263,271,300,304,319,336],"leading":[6],"cause":[7,190],"of":[8,18,54,72,88,97,133,140,144,148,161,211,254,265,302,307,321,340],"death":[10],"in":[11,50,75,100,181,195,203,239,245,262,299,310,326,342],"United":[13],"States,":[14],"with":[15,137,176,344],"cure":[16],"rates":[17],"less":[19],"than":[20],"15%.":[21],"Even":[22],"though":[23],"most":[24],"non-small":[25],"cell":[26],"lung":[27],"tumors":[29],"express":[30],"epidermal":[32],"growth":[33],"factor":[34],"receptor":[35,293],"(EGFr),":[36],"significant":[37],"clinical":[38],"responses":[39],"to":[40,60,64,108,200,260,277,283,317,323,366],"specific":[42],"tyrosine":[43],"kinase":[44,179,213],"inhibitor":[45],"(TKI)":[46],"gefitinib":[47,109,341],"are":[48,298],"seen":[49],"only":[51],"about":[52],"10%":[53],"NSCLC":[55],"patients.":[56,77],"This":[57,117,209,234,256],"has":[58],"led":[59],"some":[61],"question":[62],"as":[63,188,335,357],"whether":[65],"EGFr":[67,99,171,324,334,353],"even":[69,80],"target":[71,339],"these":[73,348],"drugs":[74],"responding":[76],"In":[78],"addition,":[79],"dramatic":[81,345],"responders":[82],"eventually":[83],"relapse":[84,162],"and":[85,163,165,197,218,224,242,274,297],"mechanism":[87],"acquired":[89,192,364],"resistance":[90,194,206,322,365],"unclear.":[92],"We":[93,289],"evaluated":[94],"sequence":[96,173],"a":[101,105,129,189,278,367],"patient":[102,127],"who":[103],"demonstrated":[104],"near-complete":[106],"response":[107,118],"after":[110,363],"relentless":[111],"progression":[112],"through":[113],"four":[114],"chemotherapeutic":[115],"regimens.":[116],"was":[119,153,174,215,229,236],"sustained":[120],"for":[121,168,191,286],"18":[122],"months":[123],"during":[124],"which":[125,182],"had":[128],"completely":[130],"normal":[131],"quality":[132],"life":[134],"before":[135],"relapsing":[136],"rapid":[138],"regrowth":[139],"tumor":[141,157,221,250],"at":[142,158,251],"one":[143],"original":[146],"sites":[147],"disease.":[149],"A":[150],"surgical":[151],"biopsy":[152],"obtained":[154],"from":[155,220,248],"time":[160,253],"DNA":[164,241],"RNA":[166,246],"prepared":[167],"analysis.":[169],"The":[170],"genomic":[172,222],"aligned":[175],"abl":[178,204],"domain":[180,214],"point":[183],"mutations":[184],"have":[185,290],"been":[186],"identified":[187,230],"TKI":[193,205],"CML":[196],"exons":[198],"analogous":[199],"those":[201],"involved":[202],"were":[207],"identified.":[208],"region":[210],"PCR":[216],"amplified":[217],"sequenced":[219],"DNA,":[223],"an":[225],"in-frame":[226],"15-nucleotide":[227],"deletion":[228,264],"within":[231,270],"exon":[232],"19.":[233],"mutation":[235,257,309,314],"not":[237],"present":[238],"somatic":[240],"expressed":[244],"isolated":[247],"relapse.":[255],"predicted":[259],"result":[261],"5":[266],"amino":[267],"acid":[268],"residues":[269],"drug-binding":[272],"pocket":[273],"immediately":[275],"adjacent":[276],"key":[279],"lysine":[280],"residue":[281],"known":[282],"be":[284,361],"important":[285,338],"drug":[287],"binding.":[288],"cloned":[291],"this":[292,308,313,329],"into":[294],"expression":[295],"constructs":[296],"process":[301],"evaluating":[303],"functional":[305],"consequences":[306],"vitro.":[311],"If":[312],"confirmed":[316],"underlie":[318],"acquisition":[320],"TKIs":[325],"additional":[327],"patients,":[328],"finding":[330],"will":[331],"strongly":[332],"support":[333],"physiologically":[337],"patients":[343],"responses.":[346],"Additionally,":[347],"data":[349],"suggest":[350],"that":[351],"non-TKI":[352],"targeting":[354],"agents":[355],"such":[356],"anti-receptor":[358],"antibodies":[359],"might":[360],"efficacious":[362],"TKI.":[368]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2020-05-13T00:00:00"}